Tools
Upgrade to Pro 🌟

Upgrade for Pro stock ideas, Al signals, and more search.

Learn More

XPH

SPDR S&P Pharmaceuticals ETF · PSE

  • Category Health Care
  • Expense Ratio 0.35%
  • Listing Date Jun 22, 2006
  • Volume 64,759.0
  • Market Cap (AUM) $159.3M

Performance

-4.15%

1W

-3.76%

1M

+4.8%

3M

+11.46%

6M

+10.71%

YTD

+25.45%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Eli Lilly and CompanyLLY5.74%
  • Intra-Cellular Therapies, Inc.ITCI5.49%
  • Elanco Animal Health, Inc.ELAN5.41%
  • Organon & Co.OGN5.41%
  • Merck & Co., Inc.MRK5.08%
  • Axsome Therapeutics, Inc.AXSM5.04%
  • Pfizer Inc.PFE4.94%
  • Catalent IncCTLT4.78%
  • Jazz Pharmaceuticals Public Limited CompanyJAZZ4.70%
  • Zoetis, Inc. Class AZTS4.57%

Technical Analysis of XPH 2024-11-20

The stock indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators Score of 46 and Technical Score of 48 suggest a slight bearish inclination. Overall, these scores imply that the stock is currently in a consolidation phase, lacking strong momentum in either direction.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.